Key statistics
As of last trade, Bavarian Nordic A/S (BV3A:DUS) traded at 9.25, 50.41% above the 52 week low of 6.15 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.30 |
---|---|
High | 9.30 |
Low | 9.25 |
Bid | 9.35 |
Offer | 9.75 |
Previous close | 9.35 |
Average volume | 215.11 |
---|---|
Shares outstanding | 236.50m |
Free float | 234.08m |
P/E (TTM) | 23.57 |
Market cap | 2.46bn USD |
EPS (TTM) | 0.4406 USD |
Data delayed at least 15 minutes, as of Nov 01 2024 11:30 BST.
More ▼
Announcements
- De første børn er vaccineret i nyt klinisk forsøg, der sigter mod at udvide indikationen for Bavarian Nordics mpox-vaccine
- First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine
- Bavarian Nordic indgår aftale med UNICEF om levering af 1 million doser mpox-vaccine
- Bavarian Nordic opjusterer sine økonomiske forventninger til 2024
- Bavarian Nordic Upgrades its Financial Guidance for 2024
- Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines
- Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines
- Bavarian Nordic modtager USD 63 mio. fra den amerikanske regering for produktion og levering af yderligere koppe- og mpoxvacciner
- Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents
- Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa
More ▼